The post approval changes are the changes made to the Medical products which have received approval from the CDSCO. The changes of the medical product that results in the impact of the changes on the quality of approved products to have an adverse effect on identity, strength, quality, purity of the Medical product as these factors may relate to the safety or effectiveness of the product. This post approval change has been implemented by CDSCO from the new rule of the Drugs and Cosmetic Rules.
The Post approval changes are the changes that are done by the manufactures when a specific change needs to be done by the manufacturer which is implemented until the product is marketable. The changes which says the specific changes that a company would like to implement during the lifecycle of the product. Such a stepwise approach that is done by our expect Morulaa team to lead faster and efficient implementation of changes for the post approval changes by the CDSCO.
There are many reasons for making changes to the Medical products after the original regulatory approval is obtained. Indian authorized agent shall inform such change to CLA (central licensing Authority) within a period of forty five days in the event of any change in the constitution of the overseas manufacturer or authorized agent. The following are the two categories under which the changes has been done by CDSCO under the Drugs and Cosmetics Rules.
- Major change ‐ Substantial potential
- Minor Change‐ Minimal potential
- Major Change:
Changes that have a substantial potential to have an adverse effect on the identity, strength, quality, purity of a biological product as these factors may relate to the safety or effectiveness of the product. Major changes require prior approval before the implementation for regulatory approval. Time period for implementation of any major changes takes 60 days. The following shall be considered as major changes.
- Material of construction
- Design which shall affect quality in respect of its specification, indication for use: performance and stability of the medical device:
- The intended use or indication for use
- The method of sterilization
- The approved Shelf Life
- The name or address of
- The domestic Manufactures or its manufacturing site
- Overseas manufactures or its manufacturing site(for import only)
- Authorized agent (for import only)
- Label excluding changes in font size, font type, color , label design
- Manufacturing process, equipment or testing which shall affect quality of the device
- Primary packaging material
2.Minor Change:
Changes that have minimal potential to have an adverse effect on the identity, strength, quality, purity, of the biological product as these factors may relate to the safety or effectiveness of the product. Minor changes don’t require prior approval before the implementation for regulatory approval. The following shall be considered as minor changes.
- Design which shall not affect quality in respect of its specification, indication for use, performance and stability of the medical device
- In manufacturing process, equipment, or testing which shall not affect quality of the device.
- Packaging specification excluding primary packaging material
Time period for implementation of any minor changes don’t need prior approval after providing the licensee information from CLA(central Licensing Authority), so within a period of thirty days after the change been applied it becomes effective.
How Morulaa Healthtech can assist you in Post Approval Changes?
- Morulaa consistently works hard with an in‐house regulatory team to conduct registration of medical device, IVDs, cosmetic in India by following CDSCO (Indian FDA)
- With all expertise Knowledge Morulaa also assist in obtaining the Import license, test license to successfully import products into India with registration and also works for all types of Post Approval Changes
- Contact us for all types of Medical device, cosmetics and IVD registration, Post approval changes registration in India
